New Senate bill aims to empower FTC to crack down on PBMs
Newswire
AHA presses for False Claims Act probes to target payers over Medicare Advantage denials
Senate Commerce Committee Issues Testimony From David A. Balto Law Offices Antitrust Attorney
Amneal must give EpiPen plaintiffs documents on PBM dealings
Improve the Pharmaceutical Ecosystem for Patients
Arkansas Sues Drugmakers, Pharmacy Benefit Managers Over Insulin Costs
Seven health insurance CEOs raked in a record $283 million last year
Massachusetts scrutinizing health care consolidation
Biden plan to slash pharmacy fees, cut seniors' out-of-pocket costs delayed until 2024
Louisiana sues health care company over practices under investigation in Ohio
How a Formulary Change and a Few Tweets Led to a HIPAA Complaint
Prospect of lower fees for prescription drugs could be dashed by new maneuver from PBMs
CEO of upstart PBM: What CVS, Cigna and other PBMs are doing in drug pricing is neither sustainable
Provider status is very necessary for pharmacists (and I will argue with AMA later on this)
Vertically integrated payer-provider groups raise antitrust concerns
Oklahoma pharmacist: 'I can tell you the system is broken'
Bipartisan pressure may prompt Federal Trade Commission to investigate drug middlemen
Yost opens investigation into PBM maneuver
More than $300 Billion in Health Care Spending Goes to Middlemen. We Need Accountability.
Pharmacy Agent Study Would Show Role in Drug Price ‘Dysfunction’
We Need Your Support Today!